Full formMedical & Health
AXLstands forAxl receptor tyrosine kinase
Full Form of AXL
What is AXL?
AXL, or Axl receptor tyrosine kinase, is a transmembrane protein encoded by the AXL gene in humans. It belongs to the TAM (Tyro3, Axl, Mer) family of receptor tyrosine kinases and plays a critical role in cell survival, proliferation, migration, and immune regulation. In the Indian context, AXL has gained significant attention in cancer research due to its overexpression in many solid tumors, including lung, breast, ovarian, and hepatocellular carcinomas. Clinicians and researchers in India study AXL to understand its involvement in tumor progression, metastasis, and drug resistance. The protein is activated by its ligand GAS6 (growth arrest-specific 6), triggering downstream signaling pathways such as PI3K/AKT and MAPK/ERK. AXL is frequently discussed in Indian medical journals, oncology conferences, and pharmacology curricula. For students preparing for NEET-PG or medical research fellowships, knowing AXL's role in targeted therapy and immune evasion is essential. Recent clinical trials in India have explored AXL inhibitors as potential treatments for resistant cancers, making it a clinically relevant marker. The use of AXL as a biomarker and therapeutic target is expected to grow in precision oncology programs across Indian hospitals.
AXL का फुल फॉर्म
एक्सएल रिसेप्टर टायरोसिन काइनेज
Example
The AXL protein is overexpressed in many Indian cancer patients, making it a target for novel therapies.
AXL — frequently asked questions
What is the full form of AXL?
AXL stands for Axl receptor tyrosine kinase, a protein involved in cell signaling and frequently studied in cancer biology.
Why is AXL important in cancer treatment?
AXL overexpression is linked to cancer progression, metastasis, and drug resistance, making it a valuable target for developing new therapies in oncology.
Is AXL relevant for Indian medical exams?
Yes, AXL appears in molecular biology and oncology sections of NEET-PG and other medical entrance exams, especially in questions related to receptor tyrosine kinases and targeted therapy.